{"resourceType":"ValueSet","id":"detectedissue-category","meta":{"lastUpdated":"2017-04-19T07:44:43.294+10:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status","valueString":"Informative"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":1},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cds"}],"url":"http://hl7.org/fhir/ValueSet/detectedissue-category","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.4.642.3.194"}],"version":"3.0.1","name":"Detected Issue Category","status":"draft","experimental":true,"date":"2017-04-19T07:44:43+10:00","publisher":"FHIR Project team","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/fhir"}]}],"description":"Kinds of issues or contraindications, such as \u0027drug-drug interaction\u0027, \u0027duplicate therapy\u0027, etc.","compose":{"include":[{"system":"http://hl7.org/fhir/v3/ActCode","filter":[{"property":"concept","op":"is-a","value":"_AdministrationDetectedIssueCode"}]},{"system":"http://hl7.org/fhir/v3/ActCode","filter":[{"property":"concept","op":"is-a","value":"_ActSuppliedItemDetectedIssueCode"}]},{"system":"http://hl7.org/fhir/v3/ActCode","filter":[{"property":"concept","op":"is-a","value":"_SupplyDetectedIssueCode"}]}]}}